IL2 and melanoma: Using an adoptive cell therapy model, Zheng et al. found that the vast majority of antigen-specific T cells reacted to IL-2-decorated liposomes in vivo after a single injection and that repeated administrations increased cytotoxic T cell activation and proliferation in melanoma-bearing mice.